APA (7th ed.) Citation

Kuo, H., Wang, K., Chen, H., Lai, Z., Lin, P., Chuang, Y., & Liu, L. Y. (2024). Cardiovascular outcomes associated with SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus and cancer: A systematic review and meta-analysis. Diabetology and metabolic syndrome, 16(1), 108-10. https://doi.org/10.1186/s13098-024-01354-4

Chicago Style (17th ed.) Citation

Kuo, Hsiao-Huai, Kuang-Te Wang, Hsin-Hao Chen, Zih-Yin Lai, Po-Lin Lin, Yung-Jen Chuang, and Lawrence Yu-Min Liu. "Cardiovascular Outcomes Associated with SGLT2 Inhibitor Therapy in Patients with Type 2 Diabetes Mellitus and Cancer: A Systematic Review and Meta-analysis." Diabetology and Metabolic Syndrome 16, no. 1 (2024): 108-10. https://doi.org/10.1186/s13098-024-01354-4.

MLA (9th ed.) Citation

Kuo, Hsiao-Huai, et al. "Cardiovascular Outcomes Associated with SGLT2 Inhibitor Therapy in Patients with Type 2 Diabetes Mellitus and Cancer: A Systematic Review and Meta-analysis." Diabetology and Metabolic Syndrome, vol. 16, no. 1, 2024, pp. 108-10, https://doi.org/10.1186/s13098-024-01354-4.